Synthesis and anti-hepatitis B virus activity of 9-(2-Deoxy-2-fluoro- β-L-arabinofuranosyl)purine nuleosides

Journal of Medicinal Chemistry

Volumn 40, Issue 17, 1997, Pages 2750-2754

  Ma, Tianwei ^a   Lin, Ju Sheng ^b   Newton, M Gary ^a   Cheng, Yung Chi ^b   Chu, Chung K ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2' DEOXY 2' FLUOROVIDARABINE; 2' FLUORO 2' DEOXYHYPOXANTHINE ARABINOSIDE; PURINE NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DERIVATIZATION; DRUG MECHANISM; DRUG STABILITY; DRUG SYNTHESIS; HEPATITIS B VIRUS; METABOLIC REGULATION; NONHUMAN; STEM CELL; STRUCTURE ACTIVITY RELATION;

ANTIVIRAL AGENTS; ARABINOFURANOSYLURACIL; HEPATITIS B VIRUS; MODELS, CHEMICAL; MODELS, MOLECULAR; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030816053     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm970233+     Document Type: Article

References (22)

1. Chu, C. K.; Ma, T.; Shanmuganathan, K.; Wang, C.; Xiang, Y.; Pai, S. B.; Yao, G.-Q.; Sommadossi, J.-P.; Cheng, Y.-C. Use of 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus. Antimicrob. Agents Chemother. 1995, 39, 979-981.
2. Pai, S. B.; Liu, S.-H.; Zhu, Y.-L.; Chu, C. K.; Cheng, Y.-C. Inhibition of hepatitis B virus by a novel L-nucleoside, 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil. Antimicrob. Agents Chemother. 1996, 40, 380-386.
3. Yao, G.-Q.; Liu, S.-H.; Chou, E.; Kukhanova, M.; Chu, C. K.; Cheng, Y.-C. Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2′-fluoro-5-methyl-β-L-arabinofuranosyluracil. Biochem. Pharmacol. 1996, 51, 941-947.
4. Chen, C.-H.; Vazquez-Padua, M.; Cheng, Y.-C. Effect of anti-human immunodeficiency virus nucleoside analogs on mitochodrial DNA and its implication for delayed toxicity. Mol. Pharmacol. 1991, 39, 625-628.
5. Parker, W. B.; Cheng, Y.-C. Mitochondrial toxicity of antiviral nucleoside analogs. J. NIH Res. 1994, 6, 57-61.
6. Cui, L.; Yoon, S.; Schinazi, R. F.; Sommadossi, J.-P. Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-β-D-arabinofuranosyl)-5-iodouracil in human. J. Clin. Invest. 1994, 95, 555-563.
7. Zoulim, F.; Aguesse, S.; Borel, C.; Trepo, C.; Cheng, Y.-C. 2′-Fluoro-5-methyl-β-L-arabinofuranosyluracil, a novel L-nucleoside analog, inhibits duck hepatitis B virus replication in primary hepatocytes and in vivo. Antiviral Res. 1996, 30, A24.
8. Tennant, B.; Jacob, J.; Graham, L. A.; Peek, S.; Du, J.; Chu, C. K. Pharmaeokinetic and pharmacodynamic studies of 1-(2-fluoro-5-methyl-β-L-arabinofuranosyl)uracil (L-FMAU) in the wood-chuck model of hepatitis B virus (HBV) infection. Antiviral Res. 1997, 34, A52, 36.
9. Ma, T. W.; Pai, S. B.; Zhu, Y.-L.; Kim, H.-B.; Wang, C.-G.; Newton, M. G.; Shanmuganathan, K.; Cheng, Y.-C.; Chu, C. K. Structure-activity relationship of 1-(2-deoxy-2-fluoro-β-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents. J. Med. Chem. 1996, 39, 2835-2843.
10. Montgomery, J. A.; Shortnacy, A. T.; Carson, D. A.; Secrist, J. A., III. 9-(2-Deoxy-2-fluoro-β-D-arabinofuranosyl)guanine: A metabolically stable cytotoxic analogue of 2′-deoxyguanosine. J. Med. Chem. 1986, 29, 2389-2392.
11. Chu, C. K.; Matulic-Adamic, J.; Huang, J.-T.; Chou, T.-C.; Burchenal, J. H.; Fox, J. J.; Watanabe, K. A. Nucleosides. CXXXV. Synthesis of some 9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purines and their biological activities. Chem. Pharm. Bull. 1989, 37, 336-339.
12. Montgomery, J. A.; Shortnacy-Fowler, A. T.; Clayton, S. D.; Riordan, J. M.; Secrist, J. A., III. Synthesis and biologic activity of 2′-fluoro-2-halo derivatives of 9-β-D-arabinofuranosyladenine. J. Med. Chem. 1992, 35, 397-401.
13. Ojwang, J. O.; Bhattacharya, B. K.; Marshall, H. B.; Korba, B. E.; Revankar, G. R.; Rando, R. F. Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)pyrrolo[2,3-d] pyrimidine. Antimicrob. Agents Chemother. 1995, 39, 2570-2573.
14. Marquez, V. E.; Tseng, C. K.-H.; Mitsuya, H.; Aoki, S.; Kelley, J. A.; Ford, H., Jr.; Roth, J. S.; Broder, S.; Johns, D. G.; Driscoll, J. S. Acid-stable 2′-fluoro purine dideoxynucleosides as active agents against HIV. J. Med. Chem. 1990, 33, 978-985.
15. Stoeckler, J. D.; Bell, C. A.; Parks, R. E., Jr.; Chu, C. K.; Fox, J. J.; Ikehara, M. C(2′)-substituted purine nucleoside analogs: Interactions with adenosine deaminase and purine nucleoside phosphorylase and formation of analog nucleotides. Biochem. Pharmacol. 1982, 31, 1723-1728.
16. Schinazi, R. F.; Chu, C. K.; Peck, A.; McMillan, A.; Mathis, R.; Cannon, D.; Jeong, L.-S.; Beach, J. W.; Choi, W.-B.; Yeola, S.; Liotta, D. C. Activities of the four optical isomers of 2′, 3′-dideoxy-3′-thiacytidine (BCH-189) against human immunodeficiency virus type-1 in human lymphocytes. Antimicrob. Agents Chemother. 1992, 39, 979-981.
17. Furman, P. A.; Davis, M.; Liotta, D. C.; Paff, M.; Frick, L. W.; Nelson, D. J.; Dornsife, R. E.; Wurster, J. A.; Wilson, L. J.; Fyfe, J. A.; Turtle, J. V.; Miller, W. H.; Condreay, L.; Averett, D. R.; Schinazi, R. F.; Painter, G. R. The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine. Antimicrob. Agents Chemother. 1992, 36, 2686-2692.
18. Revankar, G. R.; Robins, R. K. Use of the sodium salt glycosylation method in nucleoside synthesis. Nucleosides Nucleotides 1989, 8, 709-724.
19. Chou, T. S.; Becke, L. M.; O'Toole, J. C.; Carr, M. A.; Parker, B. E. Triethylamine poly(hydrogen fluorides) in the synthesis of a fluorinated nucleoside glycon. Tetrahedron Lett. 1996, 37, 17-20.
20. 13C NMR method to assign regio-and stereochemistry of (2′-deoxy-2′-fluoroarabinofuranosyl)nucleosides. Tetrahedron Lett. 1991, 32, 1287-1290.
21. max = 40.2°, γ = 176.7°, κ = -158.3°.
22. Bolon, P. J.; Wang, P.; Chu, C. K.; Gosselin, G.; Boudou, V.; Pierra, C.; Mathé, C.; Imbach, J.-L.; Faraj, A.; el Alaoui, M. A.; Sommadossi, J.-P.; Pai, S. P.; Zhu, Y.-L.; Lin, J.-S.; Cheng, Y.-C.; Schinazi, R. F. Anti-human immunodeficiency and anti-hepatitis B virus activities of β-L-2′,3′-dideoxy purine nucleosides. Bioorg. Med. Chem. Lett. 1996, 6, 1657-1662.